142 related articles for article (PubMed ID: 27505678)
1. A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis.
Kollmann K; Heller G; Schneckenleithner C; Warsch W; Scheicher R; Ott RG; Schäfer M; Fajmann S; Schlederer M; Schiefer AI; Reichart U; Mayerhofer M; Hoeller C; Zöchbauer-Müller S; Kerjaschki D; Bock C; Kenner L; Hoefler G; Freissmuth M; Green AR; Moriggl R; Busslinger M; Malumbres M; Sexl V
Cancer Cell; 2016 Aug; 30(2):359-360. PubMed ID: 27505678
[No Abstract] [Full Text] [Related]
2. A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis.
Kollmann K; Heller G; Schneckenleithner C; Warsch W; Scheicher R; Ott RG; Schäfer M; Fajmann S; Schlederer M; Schiefer AI; Reichart U; Mayerhofer M; Hoeller C; Zöchbauer-Müller S; Kerjaschki D; Bock C; Kenner L; Hoefler G; Freissmuth M; Green AR; Moriggl R; Busslinger M; Malumbres M; Sexl V
Cancer Cell; 2013 Aug; 24(2):167-81. PubMed ID: 23948297
[TBL] [Abstract][Full Text] [Related]
3. CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle.
Fan Y; Li H; Liang X; Xiang Z
Oncotarget; 2017 Mar; 8(12):19934-19946. PubMed ID: 28193906
[TBL] [Abstract][Full Text] [Related]
4. CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation.
Tigan AS; Bellutti F; Kollmann K; Tebb G; Sexl V
Oncogene; 2016 Jun; 35(24):3083-91. PubMed ID: 26500059
[TBL] [Abstract][Full Text] [Related]
5. Beyond the cell cycle: a new role for Cdk6 in differentiation.
Grossel MJ; Hinds PW
J Cell Biochem; 2006 Feb; 97(3):485-93. PubMed ID: 16294322
[TBL] [Abstract][Full Text] [Related]
6. C-glycosyl flavone from
Bevara GB; Naveen Kumar AD; Koteshwaramma KL; Badana A; Kumari S; Malla RR
Indian J Med Res; 2018 Feb; 147(2):158-168. PubMed ID: 29806604
[TBL] [Abstract][Full Text] [Related]
7. The kinase-independent, second life of CDK6 in transcription.
Otto T; Sicinski P
Cancer Cell; 2013 Aug; 24(2):141-3. PubMed ID: 23948293
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic stimulation recruits cyclin-dependent kinase in the cell cycle start in rat fibroblast.
Jinno S; Hung SC; Yamamoto H; Lin J; Nagata A; Okayama H
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13197-202. PubMed ID: 10557297
[TBL] [Abstract][Full Text] [Related]
9. Osteoclast differentiation by RANKL requires NF-kappaB-mediated downregulation of cyclin-dependent kinase 6 (Cdk6).
Ogasawara T; Katagiri M; Yamamoto A; Hoshi K; Takato T; Nakamura K; Tanaka S; Okayama H; Kawaguchi H
J Bone Miner Res; 2004 Jul; 19(7):1128-36. PubMed ID: 15176996
[TBL] [Abstract][Full Text] [Related]
10. The interplay of CDK4 and CDK6 in melanoma.
Kollmann K; Briand C; Bellutti F; Schicher N; Blunder S; Zojer M; Hoeller C
Oncotarget; 2019 Feb; 10(14):1346-1359. PubMed ID: 30858922
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Cdk6 expression through p38 MAP kinase is involved in differentiation of mouse prechondrocyte ATDC5.
Moro T; Ogasawara T; Chikuda H; Ikeda T; Ogata N; Maruyama Z; Komori T; Hoshi K; Chung UI; Nakamura K; Okayama H; Kawaguchi H
J Cell Physiol; 2005 Sep; 204(3):927-33. PubMed ID: 15795936
[TBL] [Abstract][Full Text] [Related]
12. An essential pathway links FLT3-ITD, HCK and CDK6 in acute myeloid leukemia.
Lopez S; Voisset E; Tisserand JC; Mosca C; Prebet T; Santamaria D; Dubreuil P; De Sepulveda P
Oncotarget; 2016 Aug; 7(32):51163-51173. PubMed ID: 27323399
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent Peptide Biosensor for Probing CDK6 Kinase Activity in Lung Cancer Cell Extracts.
Soamalala J; Diot S; Pellerano M; Blanquart C; Galibert M; Jullian M; Puget K; Morris MC
Chembiochem; 2021 Mar; 22(6):1065-1071. PubMed ID: 33112024
[TBL] [Abstract][Full Text] [Related]
14. The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival.
Wang H; Nicolay BN; Chick JM; Gao X; Geng Y; Ren H; Gao H; Yang G; Williams JA; Suski JM; Keibler MA; Sicinska E; Gerdemann U; Haining WN; Roberts TM; Polyak K; Gygi SP; Dyson NJ; Sicinski P
Nature; 2017 Jun; 546(7658):426-430. PubMed ID: 28607489
[TBL] [Abstract][Full Text] [Related]
15. Targeting CDK6 in cancer: State of the art and new insights.
Tadesse S; Yu M; Kumarasiri M; Le BT; Wang S
Cell Cycle; 2015; 14(20):3220-30. PubMed ID: 26315616
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma.
Easton J; Wei T; Lahti JM; Kidd VJ
Cancer Res; 1998 Jun; 58(12):2624-32. PubMed ID: 9635589
[TBL] [Abstract][Full Text] [Related]
17. Identification of G1 kinase activity for cdk6, a novel cyclin D partner.
Meyerson M; Harlow E
Mol Cell Biol; 1994 Mar; 14(3):2077-86. PubMed ID: 8114739
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and -independent effects by CDK6-specific PROTACs.
De Dominici M; Porazzi P; Xiao Y; Chao A; Tang HY; Kumar G; Fortina P; Spinelli O; Rambaldi A; Peterson LF; Petruk S; Barletta C; Mazo A; Cingolani G; Salvino JM; Calabretta B
Blood; 2020 Apr; 135(18):1560-1573. PubMed ID: 32040545
[TBL] [Abstract][Full Text] [Related]
19. p27 inhibits CDK6/CCND1 complex formation resulting in cell cycle arrest and inhibition of cell proliferation.
Li N; Zeng J; Sun F; Tong X; Meng G; Wu C; Ding X; Liu L; Han M; Lu C; Dai F
Cell Cycle; 2018; 17(19-20):2335-2348. PubMed ID: 30317923
[TBL] [Abstract][Full Text] [Related]
20. [siRNA-mediated CDK6 knockdown suppresses nasopharyngeal carcinoma cell growth and cell cycle transition in vitro].
Luo X; Xia Q; Qin J; Huang Y; Liu J; Wang Y; Wang H; Chen J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(7):1071-4. PubMed ID: 25057088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]